Back to search results

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

Abroad (travel likely)RecruitingPHASE4

Conditions

Hemophilia A With Inhibitor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

    Contact: Study coordinator (Shuo Chen) · chenshuo@ihcams.ac.cn
    Contact: Study coordinator (L Liu) · gcp@ihcams.ac.cn
    Contact: Principal Investigator (Lei Zhang)
Study leads

  • Lei Zhang

    Principal Investigator

    Chinese Academy of Medical Science and Blood Disease Hospital

  • Renchi Yang

    Principal Investigator

    Chinese Academy of Medical Science and Blood Disease Hospital

View source on ClinicalTrials.gov(opens in a new tab)